Skip to main content

Published locations for FDA approves Enhertu (trastuzumab deruxtecan) for HER2 lung cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves Enhertu (trastuzumab deruxtecan) for HER2 lung cancer

User login

  • Reset your password
  • /content/fda-approves-enhertu-trastuzumab-deruxtecan-her2-lung-cancer
  • /fedprac/article/257002/lung-cancer/fda-approves-enhertu-trastuzumab-deruxtecan-her2-lung-cancer
  • /oncologypractice/article/257002/lung-cancer/fda-approves-enhertu-trastuzumab-deruxtecan-her2-lung
  • /fedprac/avaho/article/257002/lung-cancer/fda-approves-enhertu-trastuzumab-deruxtecan-her2-lung
  • /jcomjournal/article/257002/lung-cancer/fda-approves-enhertu-trastuzumab-deruxtecan-her2-lung-cancer
  • /hematology-oncology/article/257002/lung-cancer/fda-approves-enhertu-trastuzumab-deruxtecan-her2-lung
  • /chestphysician/article/257002/lung-cancer/fda-approves-enhertu-trastuzumab-deruxtecan-her2-lung